most common glp-1 A new study from the University of Georgia put popular medications head-to-head, testing which one is the effective for weight loss GLP-1 Agonists for Type 2

Muscle mass preservation is an important consideration given the risk of sarcopenic obesity: weight loss with GLP-1 RAs includes a lean mass component (approximately 25%-40% of total weight loss), though the clinical significance in MASLD patients without sarcopenia is uncertain

the other strategy includes injectable GLP-1R agonists that mimic human GLP-1 or nonmammalian GLP-1R agonists

Fever above 100.4 F (38 C)

For example, in the DiRECT study of people with obesity and diabetes, very severe caloric restriction leading to a loss of 15% of body weight led to complete remission of type 2 diabetes in 85% of participants